Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $57,311 - $64,082
990 Added 4.92%
21,129 $1.23 Million
Q2 2023

Jul 13, 2023

BUY
$63.71 - $70.74 $20,196 - $22,424
317 Added 1.6%
20,139 $1.29 Million
Q1 2023

Apr 11, 2023

BUY
$65.71 - $74.53 $4,665 - $5,291
71 Added 0.36%
19,822 $1.37 Million
Q4 2022

Jan 23, 2023

BUY
$68.48 - $81.09 $30,747 - $36,409
449 Added 2.33%
19,751 $0
Q3 2022

Oct 19, 2022

BUY
$0.13 - $76.84 $13 - $7,760
101 Added 0.53%
19,302 $1.37 Million
Q2 2022

Jul 25, 2022

SELL
$72.62 - $79.98 $5,664 - $6,238
-78 Reduced 0.4%
19,201 $1.48 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $6,209 - $7,445
101 Added 0.53%
19,279 $1.41 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $22,953 - $26,758
428 Added 2.28%
19,178 $1.2 Million
Q3 2021

Nov 16, 2021

SELL
$59.17 - $69.31 $4,082 - $4,782
-69 Reduced 0.37%
18,750 $1.12 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $13,063 - $14,225
211 Added 1.13%
18,819 $1.26 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $23,379 - $26,295
394 Added 2.16%
18,608 $1.18 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $45,094 - $51,100
781 Added 4.48%
18,214 $1.13 Million
Q3 2020

Nov 10, 2020

BUY
$57.43 - $63.64 $23,603 - $26,156
411 Added 2.41%
17,433 $1.05 Million
Q2 2020

Jul 27, 2020

SELL
$54.82 - $64.09 $4,275 - $4,999
-78 Reduced 0.46%
17,022 $1 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $175,160 - $254,548
3,775 Added 28.33%
17,100 $942,000
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $655,723 - $855,331
13,325 New
13,325 $855,000
Q2 2019

Jul 19, 2019

SELL
$44.62 - $49.34 $57,202 - $63,253
-1,282 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $5,332 - $6,139
-89 Reduced 6.49%
1,282 $80,000
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $82,177 - $89,594
1,371
1,371 $84,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Parisi Gray Wealth Management Portfolio

Follow Parisi Gray Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parisi Gray Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Parisi Gray Wealth Management with notifications on news.